HomeCompareCI vs HRC

CI vs HRC: Dividend Comparison 2026

CI yields 2.36% · HRC yields 11.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CI wins by $131.22M in total portfolio value· pulled ahead in Year 7
10 years
CI
CI
● Live price
2.36%
Share price
$258.08
Annual div
$6.09
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$133.48M
Annual income
$123,432,595.24
Full CI calculator →
HRC
HRC
● Live price
11.38%
Share price
$155.96
Annual div
$17.74
5Y div CAGR
40.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.26M
Annual income
$1,423,429.65
Full HRC calculator →

Portfolio growth — CI vs HRC

📍 CI pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCIHRC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CI + HRC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CI pays
HRC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CI
Annual income on $10K today (after 15% tax)
$200.58/yr
After 10yr DRIP, annual income (after tax)
$104,917,705.95/yr
HRC
Annual income on $10K today (after 15% tax)
$966.88/yr
After 10yr DRIP, annual income (after tax)
$1,209,915.20/yr
At 15% tax rate, CI beats the other by $103,707,790.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CI + HRC for your $10,000?

CI: 50%HRC: 50%
100% HRC50/50100% CI
Portfolio after 10yr
$67.87M
Annual income
$62,428,012.44/yr
Blended yield
91.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CI right now

CI
Analyst Ratings
1
Strong
31
Buy
7
Hold
Consensus: Buy
Price Target
$325.83
+26.3% upside vs current
Range: $300.00 — $375.00
Altman Z
2.7
Piotroski
7/9
HRC
Analyst Ratings
7
Buy
12
Hold
1
Sell
Consensus: Hold
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CI buys
9
HRC buys
0
PoliticianChamberTickerTypeAmountDate
Julie Johnson🏢 House$CI▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$CI▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$CI▼ Sell$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$CI▼ Sell$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$CI▼ Sell$1,001 - $15,0002025-09-29
Julie Johnson🏢 House$CI▼ Sell$1,001 - $15,0002025-09-25
Ro Khanna🏢 House$CI▲ Buy$1,001 - $15,0002025-09-05
Julie Johnson🏢 House$CI▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$CI▼ Sell$1,001 - $15,0002025-08-05
Jared Moskowitz🏢 House$CI▲ Buy$1,001 - $15,0002025-05-15
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCIHRC
Forward yield2.36%11.38%
Annual dividend / share$6.09$17.74
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%40.3%
Portfolio after 10y$133.48M$2.26M
Annual income after 10y$123,432,595.24$1,423,429.65
Total dividends collected$132.70M$2.14M
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyHold

Year-by-year: CI vs HRC ($10,000, DRIP)

YearCI PortfolioCI Income/yrHRC PortfolioHRC Income/yrGap
1$11,172$471.95$12,296$1,595.93$1.1KHRC
2$12,940$985.53$15,730$2,573.05$2.8KHRC
3$15,979$2,133.55$21,147$4,316.00$5.2KHRC
4$22,022$4,924.66$30,235$7,608.15$8.2KHRC
5$36,250$12,686.29$46,615$14,263.36$10.4KHRC
6$77,820$39,032.84$78,712$28,834.27$892.00HRC
7← crossover$239,893$156,625.47$148,063$63,841.01+$91.8KCI
8$1,159,158$902,472.79$315,890$157,462.80+$843.3KCI
9$9,391,197$8,150,897.78$778,498$440,495.17+$8.61MCI
10$133,481,176$123,432,595.24$2,256,422$1,423,429.65+$131.22MCI

CI vs HRC: Complete Analysis 2026

CIHealthcare

The Cigna Group provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Full CI Calculator →

HRCStock

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. It operates in Patient Support Systems, Front Line Care, and Surgical Solutions segments. The company offers medical surgical beds, intensive care unit beds, and bariatric patient beds, lifts and other devices, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. It also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000 systems to assist patients in the mobilization of retained blockages. In addition, the company offers surgical solutions that include surgical tables, lights, and pendants; positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, it is involved in the sales and rental of products to acute and extended care facilities through direct sales force and distributors; sales and rental of products directly to patients in the home; and sales to primary care facilities through distributors. Additionally, the company offers continuum of clinical care, including acute care and primary care, as well as clinical research organizations. Hill-Rom Holdings, Inc. was founded in 1969 and is headquartered in Chicago, Illinois.

Full HRC Calculator →
📬

Get this CI vs HRC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CI vs SCHDCI vs JEPICI vs OCI vs KOCI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.